China Clinical Application Center (CCAC), formerly the Beijing Stem Cell Research Laboratory and Neurosurgical Institution, is located at Beijing, Shijingshan District, ZongGuanCun Technology Park. The clinical center covers close to 30,000-sq-ft, of which 8,000 square feet is built into a clean room in accordance to Good Manufacturing Practice (GMP) standards; approved by the China Customs biological safety risk assessment, and acquired A-grade laboratory certification from the National Health Commission of the P.R.C.
With years of experience in stem cells manufacturing, CCAC focuses much in the clinical application of stem cell transplantation and owns the largest number of CO2 incubators in China. The CCAC has been providing stem cell biologics to the General Hospital of Chinese People’s Armed Police Forces, The People’s Liberation Army No. 309 Hospital and other AAA-grade hospitals.
All clinical therapies in CCAC is conducted by Chief Medical Officer Dr.An, an internationally known stem cell therapy expert. With 14 years of experience in the clinical therapy of stem cell transplantations, he has processed over 10,000 cases, achieving an effective rate over 85%.
The CCAC has ample clinical experience and is thus capable of clinically applying the basic research results of the RMRC, forming a perfect combination between fundamental research and clinical application.